European Primary Care Cardiovascular Society

Lipid lowering: the evidence, the guidelines, the clinical reality

Mar. 17, 2018 - EPCCS 2018, Barcelona, Spain - Dr. Monika Hollander, prof. Frank Visseren, dr. Jan Oltrogge

Management of CV risk that comes with T2DM in light of novel treatment options

Mar. 15, 2018 - EPCCS 2018, Barcelona, Spain - Dr. Carlos Brotons, prof. Xavier Cos, prof. Richard Hobbs

Treatment of high-risk ACS patients may change based on ODYSSEY OUTCOMES study results

Mar. 10, 2018 - ACC 2018, Orlando, FL, USA - Dr. Valentin Fuster, New York, NY, USA

Pharmacist intervention in American 'black barbershops' effective at lowering BP

Mar. 12, 2018 - ACC 2018, Orlando, FL, USA - Dr. Ronald Victor, MD - Los Angeles, CA, USA

PCSK9 inhibitor has very good benefit-to-risk profile in high risk ACS patients in ODYSSEY OUTCOMES trial

Mar. 10, 2018 - ACC 2018, Orlando, FL, USA - Prof. Gabriel Steg - Paris, France

Striking results for weight reduction in T2DM in primary care based program

Dec. 18, 2017 - IDF 2017 - Abu Dhabi, UAE - Prof Naveed Sattar, MD - Glasgow, UK

Clinical outcomes and adverse effects comparable across various BP measurement methods in SPRINT

Nov. 20, 2017 - AHA 2017 - Anaheim, CA, USA - Dr. Sripal Bangalore - NYU Langone, New York, NY, USA.

Good BP measurement depends more on appropriate technique than on absence of staff

Nov. 25, 2017 - AHA 2017 - Anaheim, CA, USA - Prof Karen Johnson - Memphis, TN, VS

Things to consider when aiming to prevent stroke in a patient with AF

May 25, 2017
##SCROLLER_ITEMS_FULL_TITLE##

What can be learned from the latest hypertension trials?

May 26, 2017
##SCROLLER_ITEMS_FULL_TITLE##

Heart failure diagnosis and management varies substantially across European countries

May 25, 2017

How do the latest guideline changes affect management of dyslipidaemia in primary care?

May 26, 2017
##SCROLLER_ITEMS_FULL_TITLE##

Ingredients of effective strategies to stimulate behaviour change

May 25, 2017

The evidence base for health behaviour changes

Dec. 9, 2015 - EPCCS 2015 - Prague, Czech Republic

Identifying and treating patients with true hypertension

Feb. 24, 2016 - Prague - EPCCS 2015

What is the evidence base for lipid modification in the guidelines updates?

Feb. 24, 2016 - Prague - EPCCS 2015
##SCROLLER_ITEMS_FULL_TITLE##

Heart failure diagnosis and management

Dec. 9, 2015 - EPCCS 2015 - Prague

​Stroke prevention in atrial fibrillation

Mar. 12, 2014 - Amsterdam - Hobbs, Rutten

The EPCCS Stroke Prevention in Atrial Fibrillation Guidance Document 1

Jan. 7, 2014 - EPCCS 2014, Brussels - Prof. David Fitzmaurice

What's the evidence for BP and lipid targets in diabetes?

Nov. 25, 2014 - EPCCS 2014, Brussels

Decline of CV health scores and increase in CVD rates in the US

May 24, 2018 - Enserro DM, et al. - J Am Heart Assoc. 2018

CV health scores have decreased over the past 20 years, resulting in an increased risk of developing subclinical disease and incident CVD, as well as all-cause mortality.

Lipid lowering: the evidence, the guidelines, the clinical reality

Mar. 17, 2018 - EPCCS 2018, Barcelona, Spain - Dr. Monika Hollander, prof. Frank Visseren, dr. Jan Oltrogge
Despite the known efficacy of lipid-lowering therapy, in clinical reality still many patients remain at high risk, for instance due to statin intolerance. The panel discusses how to manage this, and also which risk assessment tools can be used in which patients, to guide treatment decisions.

EPCCS 2018 Despite the known efficacy of lipid-lowering therapy, in clinical reality still many patients remain at high risk, for instance due to statin intolerance. The panel discusses how to manage this, and also which risk assessment tools can be used in which patients, to guide treatment decisions.

Healthy diet and high cardiorespiratory fitness both needed to protect against CAC progression

May 16, 2018 - Gripeteg L et al. - Am J Cardiol 2018

Healthy food intake was associated with having no coronary artery calcium, and in combination with higher cardiorespiratory fitness, it was also associated with lower CAC levels.

Google searches and statin-intolerance

May 16, 2018 - news

A Google-driven nocebo effect may underlie statin intolerance, as countries with many websites on statin side-effects showed a higher prevalence of statin intolerance.

Mortality in HF predicted by simple malnutrition scores

May 16, 2018 - Sze S, et al. - J Am Coll Cardiol HF 2018

Moderate and severe malnutrition in HF patients, assessed with simple malnutrition scores, was associated with higher all-cause mortality.

Folic acid lowered stroke risk in hypertensive patients

May 16, 2018 - Kong X et al. - J Am Coll Cardiol 2018

Patients with hypertension with low platelet counts and high total homocysteine levels, which may promote platelet adherence, had the highest risk of first stroke, and this risk was reduced with folic acid treatment.

CIED function not affected by use or charging of electric car

May 8, 2018 - Lennerz C et al. - Ann Intern Med. 2018

Electric and magnetic fields generated during operation and charging of electric cars did not affect the function or programming of cardiac implantable electronic devices.

Stronger prediction of mortality by ambulatory BP than clinic BP

May 8, 2018 - Banegas JR, et al. - N Engl J Med 2018

24-hour, daytime, and nighttime ambulatory systolic blood pressure measurements were better predictors of all-cause and CV mortality compared with blood pressure measurements in the clinic.

New American guidelines result in more children with hypertension

May 7, 2018 - Sharma AK, et al. - JAMA Pediatr 2018

Based on the new blood pressure definitions for children, the estimated population prevalence of hypertension in individuals aged 5-18 years increased from 11.8% to 14.2%.

BMI trajectories from child to adult affect CV risk factors in mid-adulthood

May 7, 2018 - Buscot M-J, et al. - Eur Heart J 2018

Obesity in childhood that persists or worsens during adulthood is associated with higher risks of developing hypertension, T2DM, and dyslipidemia.

CV benefit of long-term statin treatment far outweighs adverse effects, says EAS Consensus Panel

May 3, 2018 - Mach F et al., Eur Atheroscl Soc Consensus Panel - Eur Heart J, 2018

Based on objective and critical appraisal of the literature on potential adverse effects of statins, the EAS Consensus Panel concludes that statin treatment is remarkably safe.

Conventional lipid-lowering therapy does not get heFH patients to recommended LDL-c targets

May 1, 2018 - Hartgers ML et al., - J Clin Lipidol. 2018

A model assuming 100% adherence to maximal statin dose showed that only 10% of heFH patients with CHD would reach guideline-recommended LDL-c goal, and about half of those without CHD.